The excellent clinical trial update for VAXINIA took a few days to take off after the announcement and the market hasn't even factor this news, Fast Track designation, ODD and the previous excellent clinical trial update for Azer-Cel since the pps is still lower than 14 months ago before these strengthen of the fundamental.
IMU Price at posting:
4.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)